Matrix metalloproteinase 2/9 (MMP2/9) secretion decreases by 65% in lung cancer, collagen deposition increases by 60% in stroke models, and the Treg proportion decreases by 40% and Th17 expansion increases in rheumatoid arthritis (RA) patients. Here, MMP2 is linked to lung cancer.